# Insulin glargine: UK patient leaflet, explained

Source: patient information leaflet for Lantus 100 Units/ml Solution For Injection In A Cartridge (licence PLPI219230114), approved by the MHRA. Leaflet dated 2026-11-13. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/fe613bbe9638d1ae0e0eaea2e36fb8f96c069caf

Canonical page: https://pestle.health/uk/insulin-glargine

## What is insulin glargine for?
Lantus is a long-acting modified insulin, very similar to human insulin. It is used to treat diabetes mellitus in adults, adolescents and children aged 2 years and above.

## Key facts
- Inject Lantus under the skin once a day, at the same time each day. Never inject it into a vein.
- Low blood sugar (hypoglycaemia) is very common with insulin treatment and can be very serious. Always carry some sugar with you.
- Cartridges must only be used in a reusable pen from the list in the leaflet, following the pen maker's instructions.
- Change the injection site each time to help prevent lumps or skin changes. Do not stop Lantus without speaking to a doctor.
- Tell a doctor straight away if you have signs of a severe allergic reaction.

## Who should not take insulin glargine?
- If you are allergic to insulin glargine or any of the other ingredients of this medicine

## Check with a doctor or pharmacist first if
- Lantus in cartridges is only for injecting just under the skin using a reusable pen. Speak to your doctor if you need to inject by another method
- Follow closely the instructions on monitoring (blood and urine tests), diet and physical activity agreed with your doctor
- If your blood sugar is too low (hypoglycaemia), follow the guidance in the box at the end of the leaflet
- Rotate the injection site to prevent skin changes such as lumps under the skin. The insulin may not work well in a lumpy area
- If you currently inject into a lumpy area, contact your doctor before injecting in a different area, as your doctor may tell you to check blood sugar more closely and adjust doses
- Talk to your doctor before travelling (insulin supplies, storage, meal and injection timing, time zone changes, emergencies)
- If you are ill or have a major injury, your diabetes may need a lot of care and you will usually need a doctor, so contact one early
- If you are not eating enough, your blood sugar may become too low
- If you have type 1 diabetes, do not stop your insulin, continue to get enough carbohydrates and tell people caring for you that you need insulin
- Insulin can cause antibodies to insulin, but only very rarely will this need a change in your insulin dose
- If you have long-standing type 2 diabetes with heart disease or previous stroke and take pioglitazone with insulin, tell your doctor as soon as possible about unusual shortness of breath, rapid weight increase or localised swelling (oedema), which can be signs of heart failure
- There is no experience of using Lantus in children below 2 years
- Alcohol can make your blood sugar rise or fall
- Your ability to concentrate or react may be reduced by low or high blood sugar or sight problems, so take care when driving or using machines and ask your doctor for advice if you have frequent hypoglycaemia or reduced or absent warning symptoms

## Side effects that need urgent help
- Hypoglycaemia (low blood sugar), which can be very serious, may cause you to pass out, may cause brain damage and may be life-threatening (very common, may affect more than 1 in 10 people)
- Severe allergic reactions, with signs that may include rash and itching all over the body, severe swelling of skin or mucous membranes (angioedema), shortness of breath, a fall in blood pressure with rapid heart beat and sweating. Tell a doctor straight away (rare, may affect up to 1 in 1,000 people)

## How common are the side effects?
### Very common (More than 1 in 10 people)
- Hypoglycaemia (low blood sugar)

### Common (Up to 1 in 10 people)
- Lipohypertrophy (thickening of the skin)
- Skin and allergic reactions at the injection site (reddening, unusually intense pain when injecting, itching, hives, swelling or inflammation)

### Uncommon (Up to 1 in 100 people)
- Lipoatrophy (shrinking of the skin)

### Rare (Up to 1 in 1,000 people)
- Severe allergic reactions
- Eye reactions (temporary disturbance of vision, and temporary loss of vision with severe hypoglycaemic attacks if you have proliferative retinopathy)
- General disorders (temporary build-up of water in the body, with swelling in the calves and ankles)

### Very rare (Up to 1 in 10,000 people)
- Dysgeusia (taste disorders)
- Myalgia (muscular pain)

### Not known (The leaflet says how often is not known)
- Cutaneous amyloidosis (lumps under the skin caused by build-up of a protein called amyloid)

### Not stated (The leaflet gives no frequency)
- Injection site pain (reported relatively more often in children and adolescents)
- Injection site reaction (reported relatively more often in children and adolescents)
- Rash (reported relatively more often in children and adolescents)
- Urticaria (reported relatively more often in children and adolescents)

## Other medicines the leaflet mentions
- All other medicines to treat diabetes
- ACE inhibitors
- Disopyramide
- Fluoxetine
- Fibrates
- MAO inhibitors
- Pentoxifylline, propoxyphene, salicylates (such as acetylsalicylic acid)
- Sulfonamide antibiotics
- Corticosteroids (such as cortisone)
- Danazol
- Diazoxide
- Diuretics
- Glucagon
- Isoniazid
- Oestrogens and progestogens (such as in the contraceptive pill)
- Phenothiazine derivatives
- Somatropin (growth hormone)
- Sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline)
- Thyroid hormones
- Atypical antipsychotic medicines (such as clozapine, olanzapine)
- Protease inhibitors (used to treat HIV)
- Beta-blockers
- Clonidine
- Lithium salts
- Pentamidine
- Sympatholytic medicines (such as clonidine, guanethidine, reserpine), which may weaken or hide the early warning symptoms of hypoglycaemia
- Pioglitazone (with insulin, risk of heart failure)
- Any other medicines you are taking, have recently taken or might take

## Pregnancy and breastfeeding
Tell your doctor if you are planning to become pregnant or are already pregnant, as your insulin dose may need to change during pregnancy and after birth, and careful control of diabetes is important for your baby's health. If you are breast-feeding, consult your doctor as you may need adjustments to your insulin dose and diet.

## How to take it
- Use exactly as your doctor has told you. Your doctor decides your daily dose and timing, and you need one injection every day at the same time of day.
- Inject under the skin only, never into a vein, and change the puncture site within the area of skin you use with each injection.
- Use the cartridge only in a pen listed in the leaflet (JuniorSTAR, ClikSTAR, Tactipen, Autopen 24, AllStar or AllStar PRO) and follow the pen maker's instructions.
- Keep the cartridge at room temperature for 1 or 2 hours before use and only use it if the solution is clear, colourless and waterlike with no visible particles. Do not shake, mix or dilute it, and remove air bubbles before injecting.
- Do not take a double dose to make up for a forgotten dose, and do not stop Lantus without speaking to a doctor.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
